Audit 309986

FY End
2023-12-31
Total Expended
$6.22M
Findings
0
Programs
18
Year: 2023 Accepted: 2024-06-26
Auditor: Aafcpas INC

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.242 Mental Health Research Grants $1.02M Yes 0
93.172 Human Genome Research $593,442 Yes 0
93.847 Diabetes, Digestive and Kidney Diseases Extramural Research $419,448 Yes 0
93.867 Vision Research $332,329 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $292,879 Yes 0
93.397 Cancer Centers Support Grants $178,000 Yes 0
12.750 Uniformed Services University Medical Research Projects $116,332 Yes 0
12.007 Military Health Services Research $105,369 Yes 0
12.420 Military Medical Research and Development $52,177 Yes 0
93.838 Lung Diseases Research $43,210 Yes 0
47.041 Engineering $25,109 Yes 0
93.866 Aging Research $15,202 Yes 0
93.394 Cancer Detection and Diagnosis Research $11,906 Yes 0
93.396 Cancer Biology Research $10,864 Yes 0
93.279 Drug Abuse and Addiction Research Programs $8,953 Yes 0
47.070 Computer and Information Science and Engineering $8,732 Yes 0
93.837 Cardiovascular Diseases Research $3,416 Yes 0
93.117 Preventive Medicine Residency $864 Yes 0

Contacts

Name Title Type
XEUQUDGFNN28 Marian O'Neil Auditee
8573643800 Thomas Muldoon Auditor
No contacts on file

Notes to SEFA

Title: Governmental Interagency Agreement Activities Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards includes the Federal assistance activity of BVARI and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. De Minimis Rate Used: N Rate Explanation: BVARI has elected not to use the 10% de minimis cost rate for its Federal programs. As mentioned in Note 9 to the financial statements, BVARI provides services to the VA Boston Healthcare System under a Memorandum of Understanding (MOU). Funding used under this MOU is provided through Interagency Agreements between the National Institute of Health (NIH), the Department of Defense (DoD) or Food and Drug Administration (FDA) and the Department of Veterans Affairs. BVARI provides support to the VA Precision Medicine Initiative Cohort Program (PMI-CP) for administrative, data management, extraction and storage of specimens, as well as health records and survey data, collected from Veterans who enroll into the Precision Medicine Program. BVARI provides support on the “NCI and VA Interagency Group to Accelerate Trials Enrollment” (NAVIGATE) program between NIH and the VA. Spending under the PMI-CP MOU amounted to approximately $5,816,632 for the year ended December 31, 2023. Spending under the PMI-CP (DoD) MOU amounted to approximately $440,460 for the year ended December 31, 2023. Spending under the NAVIGATE (NIH) MOU amounted to approximately $278,645 for the year ended December 31, 2023. Spending under the FDA MOU amounted to approximately $127,119 for the year ended December 31, 2023. Although these funds are sourced from the Federal government, they are not considered expenditures of Federal Grant Awards for the purpose of the Schedule of Expenditures of Federal Awards and are therefore not included on that schedule.